Radiosyntheses using Fluorine-18: The Art and Science of Late Stage Fluorination

Author(s): Erin L. Cole, Megan N. Stewart, Ryan Littich, Raphael Hoareau, Peter J. H. Scott

Journal Name: Current Topics in Medicinal Chemistry

Volume 14 , Issue 7 , 2014

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Positron (β+) emission tomography (PET) is a powerful, noninvasive tool for the in vivo, three-dimensional imaging of physiological structures and biochemical pathways. The continued growth of PET imaging relies on a corresponding increase in access to radiopharmaceuticals (biologically active molecules labeled with short-lived radionuclides such as fluorine-18). This unique need to incorporate the short-lived fluorine-18 atom (t1/2 = 109.77 min) as late in the synthetic pathway as possible has made development of methodologies that enable rapid and efficient late stage fluorination an area of research within its own right. In this review we describe strategies for radiolabeling with fluorine-18, including classical fluorine-18 radiochemistry and emerging techniques for late stage fluorination reactions, as well as labeling technologies such as microfluidics and solid-phase radiochemistry. The utility of fluorine-18 labeled radiopharmaceuticals is showcased through recent applications of PET imaging in the healthcare, personalized medicine and drug discovery settings.

Keywords: Fluorine-18, radiochemistry, radiopharmaceutical synthesis, PET imaging, positron emission tomography.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2014
Page: [875 - 900]
Pages: 26
DOI: 10.2174/1568026614666140202205035
Price: $65

Article Metrics

PDF: 111